Zardaverine

HCID 5723

Basic information

CAS
101975-10-4
Standard SMILES
COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F
InChIKey
HJMQDJPMQIHLPB-UHFFFAOYSA-N
Molecular formula
C12H10F2N2O3
Average molar mass
268.22 g/mol
Monoisotopic mass
268.06594862

Overview

Zardaverine is a pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4. It has a role as a bronchodilator agent, a peripheral nervous system drug, an anti-asthmatic drug and an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor. It is a pyridazinone and an organofluorine compound.

Names & identifiers

Preferred name
Zardaverine
IUPAC
3-[4-(difluoromethoxy)-3-methoxyphenyl]-1H-pyridazin-6-one
English name
ZARDAVERINE
Molecular formula
C12H10F2N2O3
Molecular weight
268.22

Names & synonyms

zardaverine101975-10-4ZardaverinaZardaverinumDTXSID80425596-(4-(Difluoromethoxy)-3-methoxyphenyl)-3(2H)-pyridazinoneTQ358GWH6Y6-(4-(difluoromethoxy)-3-methoxyphenyl)pyridazin-3(2H)-oneDTXCID60225596-[4-(difluoromethoxy)-3-methoxyphenyl]pyridazin-3(2H)-oneCHEBI:465486-[4-(Difluoromethoxy)-3-methoxyphenyl]-3(2H)-pyridazinone
Show more names
ZARDAVENINE3-[4-(difluoromethoxy)-3-methoxy-phenyl]-1H-pyridazin-6-one3(2H)-Pyridazinone, 6-[4-(difluoromethoxy)-3-methoxyphenyl]-
6-(4-difluoromethoxy-3-methoxyphenyl)-3(2H)pyridazinoneRefChem:904808Zardaverine [INN]6-(4-DIFLUOROMETHOXY-3-METHOXY-PHENYL)-2H-PYRIDAZIN-3-ONE6-(4-Difluoromethoxy-3-methoxyphenyl)-3(2H)-pyridazinoneCHEMBL3138423-[4-(difluoromethoxy)-3-methoxyphenyl]-1H-pyridazin-6-oneNCGC00016106-04

Database identifiers

CAS
101975-10-4
PubChem CID
5723
DTXSID
DTXSID8042559
ChEMBL
CHEMBL313842
ChEBI
CHEBI:46548
UNII
TQ358GWH6Y
Nikkaji
J326.154I

Properties

Computed structural properties

XLogP
2.2
Topological polar surface area
59.9 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
6
Rotatable bonds
4
Heavy atoms
19

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Density
1.38 · 1.38±0.1 g/cm3(Predicted)
storage temp.
Store at RT
solubility
100 mg/mL · DMSO : 100 mg/mL (372.83 mM; Need ultrasonic)
form
Off-white to yellow solid.
pka
10.89 · 10.89±0.40(Predicted)
color
White to light yellow

Safety & regulation

Safety data

PPE
Eyeshields, Gloves, type N95 (US)
wgk
3
Storage Class
11 - Combustible Solids

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Agents that cause an increase in the expansion of a bronchus or bronchial tubes.

Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.

Applications

UsesZardaverine can selectively inhibitphosphodiesterase III (PDE III) from human platelets andphosphodiesterase IV (PDE IV) from human polymorphonuclear leucocytes (PMN).

UsesBronchodilator;Phosphodiesterase III inhibitor

Upstream & downstream products

Suppliers40 total

阿诺西(上海)生物技术有限公司400-1107768 15058188853 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
Aladdin Scientific[email protected]
武汉易泰科技有限公司上海分公司18930552037 · [email protected]
United Life Science020-82099279 18988941402 · [email protected]

Additional notes

DefinitionChEBI: A pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4.

Related reactions

1 records

Compound notes

Loading…